Friday, July 31, 2026

Experience the Future: HD Construction Machinery’s Mini Electric Excavator HX19E Takes Center Stage at CONEXPO 2026

HD Construction Equipment showcased its electric excavators at CONEXPO 2026, engaging visitors with an Operator Challenge and demos.

How Korea’s Mega Projects Will Revolutionize the Biohealth Industry by 2026

South Korea's mega projects aim to revolutionize the biohealth industry through AI, semiconductors, and innovative healthcare solutions.

Breaking News: Armed conflict Between N.K. near South Korean Border

South Korean forces fired warning shots as a North Korean merchant vessel breached the Northern Limit Line, prompting its retreat.

Tag: cancer

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Korea’s First CAR-T Therapy Clears Initial Reimbursement Hurdle, With First Prescriptions Expected in October

South Korea's first CAR-T therapy, Rimkato, moves closer to national health insurance reimbursement, with commercialization expected by year-end.

AI Model Predicts Liver Function Decline Before Liver Cancer Treatment, Enabling More Personalized Care

South Korean researchers created an AI model to predict liver function decline in cancer patients, enhancing treatment safety and effectiveness.

ABL Bio to Launch Global Phase 3 Trial of ABL111 in December, Targeting First-Line Gastric Cancer Treatment

ABL Bio will begin global Phase 3 trials for its dual antibody gastric cancer treatment 'ABL111' this December after FDA discussions.

Bevacizumab Breakthrough: How Celltrion’s Vegzelma Secured Coverage in Major U.S. PBMs

Celltrion's Vegzelma gains preferred status with major U.S. PBMs, enhancing prescription access and boosting market share.

Hanmi Pharmaceutical completes acquisition of Aptose Biosciences

Hanmi Pharmaceutical has acquired Aptose Biosciences for $46.7 million, regaining rights to the cancer drug tuspetinib.

Celltrion’s Truxima becomes first rituximab biosimilar in U.S. to receive interchangeability designation

Celltrion's Truxima gains FDA interchangeability status, enhancing its market position and credibility in blood cancer treatment.

K-Bio shifts focus to clinical data as key trial readouts stack up in second half

Korea's biotech sector shifts focus to clinical data in H2 2023, with key results from leading companies expected to drive investor sentiment.

Unlocking Cancer Treatment: Samsung Bioepis Achieves Keytruda Biosimilar Equivalence in Global Trials

Samsung Bioepis' biosimilar SB27 shows equivalence to Keytruda in key clinical trials, enhancing access to cancer immunotherapy.

High cost keeps breakthrough VHL drug out of reach for Korean patients, oncologist says

Patients with Von Hippel-Lindau syndrome face high treatment costs, limiting access to essential drugs like Welireg, which could reduce surgeries.

Top 10 Breakthrough Research Projects from the 2026 UST Proposal Challenge

UST's Proposal Challenge showcased innovative student research aimed at solving social issues, with awards for top proposals in various fields.

Gilead Launches CAR-T Therapy Yescarta in Korea, Offering Fourfold Survival Benefit for Relapsed or Refractory Lymphoma Patients

Yescarta is widely used for second-line treatment in patients with very low survival rates, and should be adopted as a standard treatment in Korea.

ST Pharm Targets Next-Generation RNA Therapies, Positions Itself as Key CDMO Partner at BIO USA

The RNA therapeutics market is evolving, with ST Pharm aiming to lead in precision manufacturing and targeted delivery for next-gen therapies.

How K-AI Models Are Revolutionizing Cancer Treatment and Defense: A Deep Dive

South Korea's AI models excel in cancer care, shipbuilding, defense, and semiconductors, enhancing the nation's tech sovereignty.

Samsung Medical Center Named Asia-Pacific’s Top Hospital for Cancer, Respiratory and Digestive Care by Newsweek

Samsung Medical Center ranks top in Asia-Pacific for cancer, respiratory, and digestive care, showcasing its innovative treatments and high survival rates.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.